SC 13G

 

 

Securities and Exchange Commission

Washington, D.C. 20549

 

 

Schedule 13G

(Rule 13d-102)

Information to be Included in Statements Filed Pursuant

to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed

Pursuant to § 240.13d-2

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No.     )*

 

 

Sight Sciences, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

82657M105

(CUSIP Number)

December 31, 2021

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. 82657M105    Schedule 13G    Page 1 of 4

 

  1    

  Names of Reporting Persons

 

  Jesse Selnick

  2  

  Check the Appropriate Box if a Member of a Group (a)

 

  (a)  ☐        (b)  ☐

 

  3  

  SEC Use Only

 

  4  

  Citizenship or Place of Organization

 

  United States

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With

   5     

  Sole Voting Power

 

  2,434,984

   6   

  Shared Voting Power

 

  0

   7   

  Sole Dispositive Power

 

  2,434,984

   8   

  Shared Dispositive Power

 

  0

  9    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  2,434,984

10  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11  

  Percent of Class Represented by Amount in Row 9

 

  5.1%

12  

  Type of Reporting Person

 

  IN


CUSIP No. 82657M105    Schedule 13G    Page 2 of 4

 

ITEM 1.

(a)   Name of Issuer:

Sight Sciences, Inc. (the “Issuer”).

 

  (b)

Address of Issuer’s Principal Executive Offices:

4040 Campbell Avenue, Suite 100, Menlo Park, California 94025

 

ITEM 2.

(a)   Name of Person Filing:

This statement is filed on behalf of Jesse Selnick (the “Reporting Person”).

 

  (b)

Address or Principal Business Office:

The business address of the Reporting Person is c/o Sight Sciences, Inc., 4040 Campbell Avenue, Suite 100, Menlo Park, California 94025.

 

  (c)

Citizenship of each Reporting Person is:

Jesse Selnick is a citizen of the United States.

 

  (d)

Title of Class of Securities:

Common Stock, par value $0.001 per share (“Common Stock”).

 

  (e)

CUSIP Number:

82657M105

 

ITEM 3.

Not applicable.

 

ITEM 4.

Ownership.

(a-c)

The ownership information presented below represents beneficial ownership of Common Stock of the Issuer as of December 31, 2021, based upon 47,307,477 shares of Common Stock outstanding as of November 8, 2021, based on the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021.


CUSIP No. 82657M105    Schedule 13G    Page 3 of 4

 

Reporting Person   

Amount

beneficially

owned

    

Percent

of class:

    Sole power
to vote or to
direct the
vote:
     Shared power
to vote or to
direct the vote:
    

Sole

power to
dispose or
to direct
the
disposition

of:

    

Shared

power to

dispose or

to direct

the

disposition

of:

 

Jesse Selnick

     2,434,984        5.1     2,434,984        0        2,434,984        0  

The Reporting Person is the beneficial owner of 2,434,984 shares of Common Stock, which consists of (i) 10,000 shares of Common Stock held of record by the Reporting Person, (ii) 2,219,568 shares of Common Stock held of record by Sight Sciences Angels, LP, of which Jesse Selnick is the Managing Member of the General Partner, and (iii) 205,416 shares of Common Stock underlying stock options held by the Reporting Person that are exercisable prior to March 1, 2022. As a result, Jesse Selnick may be deemed to share beneficial ownership over the securities reported herein.

 

ITEM 5.

Ownership of Five Percent or Less of a Class.

Not applicable.

 

ITEM 6.

Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

 

ITEM 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Not applicable.

 

ITEM 8.

Identification and Classification of Members of the Group.

Not applicable.

 

ITEM 9.

Notice of Dissolution of Group.

Not applicable.

 

ITEM 10.

Certification.

Not applicable.


CUSIP No. 82657M105    Schedule 13G    Page 4 of 4

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 14, 2022

 

Jesse Selnick

/s/ Jesse Selnick